Olivera A A, Fero D, Scibilia J
Western Reserve Psychiatric Hospital, Northfield, Ohio 44167.
Am J Drug Alcohol Abuse. 1991 Sep;17(3):295-305. doi: 10.3109/00952999109027553.
The study of the dexamethasone suppression test (DST) in 374 chronic psychiatric patients with concurrent substance dependence, including alcohol, found 97% of nonsuppression associated with affective disorders. The incidence of nonsuppression was 38.5% in major depressive disorder and 27.7% in bipolar affective disorder. This study found no apparent connection between the incidence of nonsuppression and any particular drug group. Predexamethasone plasma concentrations were higher in affective disorders than in other diagnoses. It is concluded that the DST may be of value as part of the clinical approach to the diagnosis of major depressive disorders in a substance-abusing population.
对374名同时患有包括酒精在内的物质依赖的慢性精神病患者进行的地塞米松抑制试验(DST)研究发现,97%的不抑制情况与情感障碍有关。在重度抑郁症中,不抑制的发生率为38.5%,在双相情感障碍中为27.7%。该研究发现,不抑制的发生率与任何特定药物组之间没有明显联系。情感障碍患者的地塞米松前血浆浓度高于其他诊断患者。结论是,DST作为对物质滥用人群中重度抑郁症进行临床诊断的一部分可能具有价值。